Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sandoz Group AG's inventories, raw materials & components for the quarter that ended in Jun. 2026 was $0 Mil.
Sandoz Group AG's quarterly raw materials
increased
from Jun. 2025 ($0 Mil) to Dec. 2025 ($204 Mil) but then
declined
from Dec. 2025 ($204 Mil) to Jun. 2026 ($0 Mil).
Sandoz Group AG's annual raw materials
declined
from Dec. 2023 ($209 Mil) to Dec. 2024 ($192 Mil) but then
increased
from Dec. 2024 ($192 Mil) to Dec. 2025 ($204 Mil).
Sandoz Group AG Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for Sandoz Group AG's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sandoz Group AG Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of $0 Mil mean?
Sandoz Group AG (SDZXF) has a Inventories, Raw Materials & Components of $0 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Inventories, Raw Materials & Components too high?
Sandoz Group AG's current Inventories, Raw Materials & Components is $0 Mil. Overall, Sandoz Group AG has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Sandoz Group AG's Inventories, Raw Materials & Components of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Inventories, Raw Materials & Components is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Based on GuruFocus' analysis, Sandoz Group AG (SDZXF) is currently considered Significantly Overvalued. The stock's GF Value™ is $58.24, compared to a current price of $90.04 — trading 54.6% above its estimated fair value. The current Inventories, Raw Materials & Components is $0 Mil. Sandoz Group AG's overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Inventories, Raw Materials & Components is $0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sandoz Group AG (SDZXF) Overvalued in 2026?
Based on GuruFocus' analysis, Sandoz Group AG stock appears to be overvalued.
The current stock price of $90.04 is trading 54.6% above its estimated GF Value™ of $58.24.
GuruFocus considers Sandoz Group AG to be Significantly Overvalued.
Key valuation signals for SDZXF:
Inventories, Raw Materials & Components: $0 Mil
GF Value™: $58.24 vs. price of $90.04 (54.6% above fair value)
No single metric tells the full story. See the SDZXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
34GF Score
Get the complete analysis for SDZXF
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDZXF has been successfully added to your 
